PB

Prokwana Barman

Active Director Additional Director DIN 11241272
DIN 11241272 First appointment Aug 2025 Primary industry Biotechnology
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value •••• Premium profile

About Prokwana Barman

Data last updated:

Prokwana Barman is an Additional Director at Nutri Pharma Vaccines Private Limited (since 2025). The company operates in Biotechnology. Nutri Pharma Vaccines Private Limited reported revenue of ₹25.69 Cr (FY 2025).

DIN 11241272
Primary Designation Additional Director
Industry Biotechnology
First Appointment 13 Aug 2025
Largest company Nutri Pharma Vaccines Private Limited · ₹25.69 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director13 Aug 2025₹25.69 Cr (FY 2025)Active

Board colleagues of Prokwana Barman

Directorship timeline

Open interactive timeline →
Nutri Pharma Vaccines Private Limited
Premium access

Shareholding and investment profile for Prokwana Barman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prokwana Barman

Prokwana Barman currently holds 1 directorship: Nutri Pharma Vaccines Private Limited (Additional Director, since 13 Aug 2025, revenue ₹25.69 Cr (FY 2025)).

Prokwana Barman was first appointed on 13 Aug 2025 as Additional Director at Nutri Pharma Vaccines Private Limited.

The current boards of Prokwana Barman's companies include Rabindranath Barman (Nutri Pharma Vaccines Private Limited), Spandana Chaudhury (Nutri Pharma Vaccines Private Limited), Sumit Chaudhury (Nutri Pharma Vaccines Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available